NK

Nilesh Kishorbhai Limbasiya

Active Director Director DIN 11625203
DIN 11625203 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilesh Kishorbhai Limbasiya

Data last updated:

Nilesh Kishorbhai Limbasiya is a Director at Zenmark Pharmaceutical Private Limited (since 2026).

DIN 11625203
Primary Designation Director
First Appointment 23 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20262026Active

Directorship timeline

Open interactive timeline →
Zenmark Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nilesh Kishorbhai Limbasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Kishorbhai Limbasiya

Nilesh Kishorbhai Limbasiya currently holds 1 directorship: Zenmark Pharmaceutical Private Limited (Director, since 23 Mar 2026).

Nilesh Kishorbhai Limbasiya was first appointed on 23 Mar 2026 as Director at Zenmark Pharmaceutical Private Limited.

The current boards of Nilesh Kishorbhai Limbasiya's companies include Amit Maganbhai Pipaliya (Zenmark Pharmaceutical Private Limited), Jalpa Tarunkumar Kapupara (Zenmark Pharmaceutical Private Limited), Jayesh Vitthalbhai Donga (Zenmark Pharmaceutical Private Limited), Nileshkumar Vallabhdas Butani (Zenmark Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available